---
figid: PMC7174681__fgene-11-00349-g001
figtitle: ER, mTOR, and CDK4/6 pathways and their links are shown
organisms:
- Homo sapiens
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC7174681
filename: fgene-11-00349-g001.jpg
figlink: pmc/articles/PMC7174681/figure/F1/
number: F1
caption: The ER, mTOR, and CDK4/6 pathways and their links are shown. Arrows indicate
  activation; arrows ending with oval tips indicate inhibition; P means phosphorylation.
  It can be observed the presence of positive feedback loops that maintain the three
  pathways. In particular, mTOR pathway components sustain estrogen pathway by activating
  ER independently of its ligands. Estrogen pathway sustains mTOR pathway by increasing
  the expression of its upstream receptors and ligands. Additionally, estrogen and
  mTOR pathways reinforce CDK4/6 pathway through cyclin D expression. It should be
  noted that PI3K can also inhibit ER. ER, estrogen receptor; PI3K, Phosphatidylinositol
  3-kinase regulatory subunit alpha; PIP3, phosphatidylinositol (3,4,5)-trisphosphate;
  PIP2, phosphatidylinositol (4,5)-bisphosphate; PTEN, phosphatase and tensin homolog;
  AKT, serine/threonine kinase 1; PDK1, pyruvate dehydrogenase kinase 1; mTOR, mammalian
  target of rapamycin; mTORC1, mTOR complex 1; mTORC2, mTOR complex 2; mLST8, mammalian
  lethal with SEC13 protein 8, also known as G protein beta subunit-like (GβL); Raptor,
  regulatory-associated protein of mTOR; PRAS40, Proline-rich AKT1 substrate 1; Deptor,
  DEP domain-containing mTOR-interacting protein; RICTOR, Rapamycin-insensitive companion
  of mammalian target of rapamycin; SIN1, mammalian stress-activated protein kinase
  interacting protein 1; S6K1, ribosomal protein S6 kinase B1; eIF4A, eukaryotic initiation
  factor-4A; HIFα, hypoxia inducible factor 1 subunit alpha; Rb, retinoblastoma protein;
  CDK4, cyclin dependent kinase 4; CDK6, cyclin dependent kinase 6; E2F, transcription
  factor.
papertitle: 'Sequential or Concomitant Inhibition of Cyclin-Dependent Kinase 4/6 Before
  mTOR Pathway in Hormone-Positive HER2 Negative Breast Cancer: Biological Insights
  and Clinical Implications.'
reftext: Giulia Occhipinti, et al. Front Genet. 2020;11:349.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9538251
figid_alias: PMC7174681__F1
figtype: Figure
redirect_from: /figures/PMC7174681__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7174681__fgene-11-00349-g001.html
  '@type': Dataset
  description: The ER, mTOR, and CDK4/6 pathways and their links are shown. Arrows
    indicate activation; arrows ending with oval tips indicate inhibition; P means
    phosphorylation. It can be observed the presence of positive feedback loops that
    maintain the three pathways. In particular, mTOR pathway components sustain estrogen
    pathway by activating ER independently of its ligands. Estrogen pathway sustains
    mTOR pathway by increasing the expression of its upstream receptors and ligands.
    Additionally, estrogen and mTOR pathways reinforce CDK4/6 pathway through cyclin
    D expression. It should be noted that PI3K can also inhibit ER. ER, estrogen receptor;
    PI3K, Phosphatidylinositol 3-kinase regulatory subunit alpha; PIP3, phosphatidylinositol
    (3,4,5)-trisphosphate; PIP2, phosphatidylinositol (4,5)-bisphosphate; PTEN, phosphatase
    and tensin homolog; AKT, serine/threonine kinase 1; PDK1, pyruvate dehydrogenase
    kinase 1; mTOR, mammalian target of rapamycin; mTORC1, mTOR complex 1; mTORC2,
    mTOR complex 2; mLST8, mammalian lethal with SEC13 protein 8, also known as G
    protein beta subunit-like (GβL); Raptor, regulatory-associated protein of mTOR;
    PRAS40, Proline-rich AKT1 substrate 1; Deptor, DEP domain-containing mTOR-interacting
    protein; RICTOR, Rapamycin-insensitive companion of mammalian target of rapamycin;
    SIN1, mammalian stress-activated protein kinase interacting protein 1; S6K1, ribosomal
    protein S6 kinase B1; eIF4A, eukaryotic initiation factor-4A; HIFα, hypoxia inducible
    factor 1 subunit alpha; Rb, retinoblastoma protein; CDK4, cyclin dependent kinase
    4; CDK6, cyclin dependent kinase 6; E2F, transcription factor.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EGF
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PGF
  - TGFA
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - AKT1
  - AKT2
  - AKT3
  - PDK1
  - PDPK1
  - MTOR
  - RPTOR
  - MLST8
  - DEPTOR
  - PTEN
  - MAPKAP1
  - RICTOR
  - AKT1S1
  - RPS6KB1
  - HIF1A
  - EPAS1
  - HIF3A
  - EIF4E
  - EIF4E2
  - EIF4E3
  - CCND1
  - CCND2
  - CCND3
  - CDK6
  - CDK4
  - WARS1
  - IRS1
  - Akt
  - Pdk1
  - Crtc
  - Mtor
  - Tor
  - Lst8
  - raptor
  - Pten
  - PRAS40
  - rictor
  - Sin1
  - S6k
  - sima
  - eIF4E1
  - eIF4E7
  - eIF4E4
  - eIF4E5
  - eIF4E3
  - eIF4E6
  - eIF4EHP
  - rb
  - CycD
  - Cdk4
  - Egfr
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - anon-70Dc
---
